Intereleukin-10 Promoter Polymorphism in Mild Cognitive Impairment and in Its Clinical Evolution

Table 1

Distribution of genotype and allele frequencies of −1082 (G/A) SNP in Alzheimer’s disease patients (AD), control subjects (CT), and mild cognitive impairment patients (MCI).

	GG (H)	GA (M)	AA (L)	G	A
AD	4 (6.4%)	28 (44.4%)	31 (49.2%)	36 (28.6%)	90 (71.4%)
CT	14 (22.2%)	29 (46%)	20 (31.8%)	57 (45.2%)	69 (54.8%)
MCI	21 (15.2%)	71 (51.4%)	46 (33.3%)	113 (40.9%)	163 (59.1%)

Genotype: 𝜒² 9.480, d.f. 4; 𝑃=.05.
Allele: 𝜒² 8.257, d.f. 2; 𝑃=.02.